Pharmaceutical innovation : incentives, competition, and cost-benefit analysis in international perspective / edited by Frank A. Sloan, Chee-Ruey Hsieh

• Introduction / Frank A. Sloan and Chee-Ruey Hsieh -- The pharmaceutical sector in health care / Uwe E. Reinhardt -- The economics of research and development in the pharmaceutical industry / William S. Comanor -- Drugs for neglected diseases: new incentives for innovation / Aidan Hollis -- When patents fail: finding new drugs for the developing world / Stephen M. Maurer -- Implementing a public subsidy for vaccines / Frank A. Sloan and Charles E. Eesley -- Ensuring the future supply of vaccines: is a national vaccine authority the answer? / Frank R. Lichtenberg -- Competition between generic and branded drugs / Henry Grabowski -- The United States' experience with direct-to-consumer advertising of prescription drugs: what have we learned? / Ernst R. Berndt -- Measures of costs and benefits for drugs in cost-effectiveness analysis / Mark V. Pauly -- Using economic evaluation in reimbursement decisions for health technologies: lessons from international experience / Michael Drummond -- Pharmaceutical spending and health outcomes / Pierre-Yves Cremieux ... [et al.] -- Pharmaceutical innovation and health outcomes: empirical evidence from Taiwan / Chee-Ruey Hsieh ... [et al.] -- Conclusions and policy implications / Frank A. Sloan and Chee-Ruey Hsieh.

Ämnesord

Pharmaceutical policy.  (LCSH)

Pharmaceutical industry.  (LCSH)

Drug development  -- Technological innovations -- Economic aspects. (LCSH)

Drug Industry  -- economics. (MeSH)

Cost-Benefit Analysis.  (MeSH)

Economic Competition.  (MeSH)

Health Policy.  (MeSH)

Pharmaceutical Preparations  -- economics. (MeSH)

Vaccines  -- economics. (MeSH)

Klassifikation

RA401.A1 (LCC)

338.4/76151 (DDC)

Pmc (kssb/8)